000 01564 a2200409 4500
005 20250513150413.0
264 0 _c19980825
008 199808s 0 0 eng d
022 _a0306-5456
024 7 _a10.1111/j.1471-0528.1998.tb10203.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRegan, C L
245 0 0 _aReduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies.
_h[electronic resource]
260 _bBritish journal of obstetrics and gynaecology
_cJul 1998
300 _a732-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _a6-Ketoprostaglandin F1 alpha
_xanalogs & derivatives
650 0 4 _aAdult
650 0 4 _aAspirin
_xadministration & dosage
650 0 4 _aCyclooxygenase Inhibitors
_xadministration & dosage
650 0 4 _aDelayed-Action Preparations
650 0 4 _aDouble-Blind Method
650 0 4 _aEicosanoids
_xurine
650 0 4 _aFemale
650 0 4 _aFetal Blood
_xchemistry
650 0 4 _aHumans
650 0 4 _aPre-Eclampsia
_xdrug therapy
650 0 4 _aPregnancy
650 0 4 _aThromboxane B2
_xmetabolism
700 1 _aMcAdam, B F
700 1 _aMcParland, P
700 1 _aBoylan, P C
700 1 _aFitzGerald, G A
700 1 _aFitzgerald, D J
773 0 _tBritish journal of obstetrics and gynaecology
_gvol. 105
_gno. 7
_gp. 732-8
856 4 0 _uhttps://doi.org/10.1111/j.1471-0528.1998.tb10203.x
_zAvailable from publisher's website
999 _c9658067
_d9658067